ANALYSIS OF THE PREVALENCE OF THE GLOBAL BURDEN OF LEUKEMIA AMONG CENTRAL ASIAN COUNTRIES FROM 2014 TO 2019 YEARS
Introduction. Leukemia is a common malignancy that has four main subtypes and is a threat to human health. Understanding the epidemiological status of leukemia and its four main subtypes globally is important for allocating appropriate resources, guiding clinical practice, and furthering scientific research
Objective: Analysis of data on the global burden of leukemia among the countries of Central Asia for the period from 2014 to 2019.
Material and methods: An analysis of the main indicators of the burden of leukemia was carried out using the Global Burden of Disease database (GBD 2019) for the period from 2014–2019. We calculated 3 secondary measures of the ratio of disability-adjusted life years (DALY) to prevalence, the ratio of prevalence to incidence, and the ratio of years of life lost (YLL) to years lived with disability (YLD).
Results: For the period from 2014 to 2019, high rates of YLL, DALY were registered among such countries as Georgia, Azerbaijan and Armenia. Regarding the YLD indicator, the highest indicator is registered in the Russian Federation. It is also important to note that in the Republic of Kazakhstan there is a trend of an annual increase in the YLD indicator. While there is a slight downward trend in the burden of leukemia as measured by YLL, DALY, the average annual percentage changes (AAPCs) ranged from -1.34% to 1.38% in the Republic of Kazakhstan between 2014 and 2019.
Conclusion: Between 2014 and 2019, there was a significant decrease in the burden of leukemia. However, in 2019 YLD increased significantly in some Central Asian countries, suggesting that leukemia could become a major global public health problem.
Aliya K. Atabayeva1, http://orcid.org/0000-0001-7725-2255
Zaituna A. Khismetova1, https://orcid.org/0000-0001-5937-3045
Saule B. Makaeva1, https://orcid.org/0000-0002-1518-6528
Sholpan U. Aliyeva2, https://orcid.org/0000-0002-9717-2807
Maria U. Anartaeva3, https://orcid.org/0000-0003-1087-6578
Kamila M. Akhmetova4, https://orcid.org/0009-0009-6257-4337
Evgeny L. Borshchuk4, https://orcid.org/0000-0002-0973-6343
1 NCJSC «Semey Medical University», Semey, Republic of Kazakhstan;
2 JSC "Central Clinical Hospital", Almaty, Republic of Kazakhstan;
3 JSC "South Kazakhstan Medical Academy", Shymkent, Republic of Kazakhstan;
4 RSE at the National Research Center for Health Development named after Salidat Kairbekova,
Astana, Republic of Kazakhstan;
5 Federal State Budgetary Educational Institution of Higher Education "Orenburg State Medical University" of the Ministry of Health of Russia, Orenburg, Russian Federation.
1 Атабаева А.К., Хисметова З.А. Эпидемиология новообразований системы крови. Обзор литературы // Наука и здравоохранение. 2021. 5:188–197
2. Adelman E.R., Shi J., Figueroa M.E. Aging Human Hematopoietic Stem Cells Manifest Massive Epigenetic Reprogramming and Altered Gene Splicing of Key Hematopoietic Gene Sets // Blood. 2016. 128:885–885. https://doi.org/10.1182/blood.v128.22.885.885
3. Alvarez A.E.B., Rubio A.J., Gonzalez M.A., Eiring A.M. Blood cancer health disparities in the United States Hispanic population // Cold Spring Harbor Molecular Case Studies 2021. 7:a005967
4. Baeker Bispo J.A., Pinheiro P.S., Kobetz E.K. Epidemiology and etiology of leukemia and lymphoma // Cold Spring Harbor Perspectives in Medicine. 2020. 10:a034819. https://doi.org/10.1101/cshperspect.a034819
5. Bailey H.D, Metayer C., Milne .E, et al Home paint exposures and risk of childhood acute lymphoblastic leukemia: findings from the Childhood Leukemia International Consortium // Cancer Causes and Control. 2015. 26:1257–1270. https://doi.org/10.1007/s10552-015-0618-0
6. Bailey H.D., Fritschi L., Infante-Rivard C. et al. Parental occupational pesticide exposure and the risk of childhood leukemia in the offspring: Findings from the childhood leukemia international consortium // International Journal of Cancer. 2014. 135:2157–2172. https://doi.org/10.1002/ijc.28854
7. Bonaventure A., Harewood R., Stiller C.A. et al Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries // The Lancet Haematology 2017. 4:e202-e217. https://doi.org/10.1016/S2352-3026(17)30052-2
8. Carlos-Wallace F.M., Zhang L., Smith M.A.T. et al. Parental, in Utero, and Early-Life Exposure to Benzene and the Risk of Childhood Leukemia: A Meta-Analysis. American Journal of Epidemiology. 2016. 183:1–14
9. Chen A., Jacobsen K.H., Deshmukh A.A., Cantor S.B. The evolution of the disability-adjusted life year (DALY) // Socio-Economic Planning Sciences. 2015. 49:10–15. https://doi.org/10.1016/j.seps.2014.12.002
10. Chunxia D., Meifang W., Jianhua Z. et al. Tobacco smoke exposure and the risk of childhood acute lymphoblastic leukemia and acute myeloid leukemia: A meta-Analysis // Medicine (United States) 2019. 98:e16454
11. Dong Y., Shi O., Zeng Q. et al. Leukemia incidence trends at the global, regional, and national level between 1990 and 2017 // Experimental Hematology and Oncology, 2020. 9:14. https://doi.org/10.1186/s40164-020-00170-6
12. Erratum: Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 // The Lancet, 2019. 393:P. e44
13. Force L.M., Abdollahpour I., Advani S.M. et al. The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017. The Lancet Oncology 2019. 20:1211–1225. https://doi.org/10.1016/S1470-2045(19)30339-0
14. Institute for Health Metrics GBD Compare | Institute for Health Metrics and Evaluation. Seattle, WA: IHME, University of Washington. 2020 Electronic resource available from: https://www.healthdata.org/data-visualization/mortality-visualization (Дата обращения: 01.02.2023).
15. Kneale G.W. Risk of childhood cancer from fetal irradiation: 2. The British journal of radiology. 1997. 70:770–771
16. Kocarnik J.M., Compton K., Dean F.E. et al. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019 // JAMA Oncology. 2022. 8:420–444. https://doi.org/10.1001/jamaoncol.2021.6987
17. Kuehl W.M., Bergsagel P.L. Molecular pathogenesis of multiple myeloma and its premalignant precursor // Journal of Clinical Investigation. 2012. 122:3456–3463
18. Kulkayeva G.U., Kemaykin V.M., Kuttymuratov A.M. et al. First report from a single center retrospective study in Kazakhstan on acute myeloid leukemia treatment outcomes // Scientific Reports. 2021, 11:24001. https://doi.org/10.1038/s41598-021-03559-3
19. Lin X., Wang J., Huang X. et al. Global, regional, and national burdens of leukemia from 1990 to 2017: a systematic analysis of the global burden of disease 2017 study Aging 2021. 13:10468–10489. https://doi.org/10.18632/aging.202809
20. Liu R., Zhang L., McHale C.M., Hammond S.K.. Paternal smoking and risk of childhood acute lymphoblastic leukemia: systematic review and meta-analysis // J Oncol. 2011 :854584. doi:10.1155/2011/854584.
21. Mahajan M. The IHME in the Shifting Landscape of Global Health Metrics // Global Policy. 2019. 10:110–120. https://doi.org/10.1111/1758-5899.12605
22. Mayer R.L., Schwarzmeier J.D., Gerner M.C. et al Proteomics and metabolomics identify molecular mechanisms of aging potentially predisposing for chronic lymphocytic leukemia. Molecular and Cellular Proteomics 17:290–303, 2018. https://doi.org/10.1074/mcp.RA117.000425
23. Merhi M., Raynal H., Cahuzac E. et al Occupational exposure to pesticides and risk of hematopoietic cancers: Meta-analysis of case-control studies // Cancer Causes and Control 2007. 18:1209–1226. https://doi.org/10.1007/s10552-007-9061-1
24. Mills A. Health Care Systems in Low- and Middle-Income Countries // New England Journal of Medicine. 2014. 370:552–557. https://doi.org/10.1056/nejmra1110897
25. Nagai H., Kim Y.H. Cancer prevention from the perspective of global cancer burden patterns // Journal of Thoracic Disease. 2017, 9:448–451
26. Nielsen L.K., Jarden M., Andersen C.L. et al. Health-Related Quality of Life (HRQoL) Measurements in Multiple Myeloma Patients Obtained By EORTC QLQ-C30; A Critical Review of Interpreting HRQoL Data in Longitudinal Studies // Blood. 2016. 128:540–540. https://doi.org/10.1182/blood.v128.22.540.540
27. Ou Z., Yu D., Liang Y. et al 2020 Analysis of the Global Burden of Disease study highlights the trends in death and disability-adjusted life years of leukemia from 1990 to 2017 // Cancer Communications 40:598–610. https://doi.org/10.1002/cac2.12094
28. Patel M.I., Lopez A.M., Blackstock W. et al. Cancer disparities and health equity: A policy statement from the american society of clinical oncology // Journal of Clinical Oncology. 2020. 38:3439–3448. https://doi.org/10.1200/JCO.20.00642
29. Piccirillo J.F., Vlahiotis A., Barrett L.B. et al. The changing prevalence of comorbidity across the age spectrum // Critical Reviews in Oncology/Hematology. 2008 .67:124–132
30. Rodriguez-Abreu D., Bordoni A., Zucca E. Epidemiology of hematological malignancies // Annals of Oncology. 2007. 18:3–i8. https://doi.org/10.1093/annonc/mdl443
31. Rowe J.W., Fulmer T., Fried L. Preparing for better health and health care for an aging population. JAMA - Journal of the American Medical Association. 2016. 316:1643–1644. 2016
32. Siegel R.L., Miller K.D., Fuchs H.E., Jemal A. Cancer Statistics, 2021 // CA: A Cancer Journal for Clinicians. 2021 71:7–33. https://doi.org/10.3322/caac.21654
33. Spector L.G., Marcotte E.L., Kehm R., Poynter J.N. Epidemiology and hereditary aspects of acute leukemia // Neoplastic Diseases of the Blood. 2018. pp 179–195
34. Stevens G.A., Alkema L., Black R.E. et al. Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement // The Lancet. 2016. 388:e19–e23
35. Stieglitz E., Loh M.L. Genetic predispositions to childhood leukemia // Therapeutic Advances in Hematology. 2013. 4:270–290. https://doi.org/10.1177/2040620713498161
36. Sung H., Ferlay J., Siegel R.L. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians 2021. 71:209–249. https://doi.org/10.3322/caac.21660
37. Taylor J., Xiao W., Abdel-Wahab O. Diagnosis and classification of hematologic malignancies on the basis of genetics // Blood. 2017. 130:410–423
38. Verovskaya E V., Dellorusso P V., Passegué E Losing Sense of Self and Surroundings: Hematopoietic Stem Cell Aging and Leukemic Transformation. Trends in Molecular Medicine 2019. 25:494–515
39. Whitehead T.P., Metayer C., Wiemels J.L. et al. Childhood Leukemia and Primary Prevention. Current Problems in Pediatric and Adolescent. Health Care. 2016. 46:317–352. https://doi.org/10.1016/j.cppeds.2016.08.004
40. World Health Organization Global health estimates for 2020: deaths by cause, age, sex, by country and by region, 2000-2019 // Who, 2020. 1–59.
41. Zhou L., Deng Y., Li N. et al. Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: Estimates from the 2017 Global Burden of Disease study // Journal of Hematology and Oncology. 2019. 12:107. https://doi.org/10.1186/s13045-019-0799-1
42. Zhou Y., Zhang S., Li Z., et al. Maternal benzene exposure during pregnancy and risk of childhood acute lymphoblastic leukemia: A meta-analysis of epidemiologic studies // PLoS ONE. 2014. 9:e110466. https://doi.org/10.1371/journal.pone.0110466
43. Zon R.T., Frame J.N., Neuss M.N. et al. American society of clinical oncology policy statement on clinical pathways in oncology // Journal of Oncology Practice. 2016. 12:261–266. https://doi.org/10.1200/JOP.2015.009134
References: [1]
1. Atabaeva A.K., Hismetova Z.A. Epidemiologiya novoobrazovanii sistemy krovi. Obzor literatury [Epidemiology of neoplasms of the blood system. Literature review]. Nauka i zdravoohranenie [Science & Healthcare ] 2021. 5 (V.23). pp.188–197. [in Russian]
Number of Views: 83
Category of articles:
Original articles
Bibliography link
Atabayeva A.K., Khismetova Z.A., Makaeva S.B., Aliyeva Sh.U., Anartaeva M.U., Akhmetova K.M., Borshchuk Ye.L. Analysis of the prevalence of the global burden of leukemia among Central Asian countries from 2014 to 2019 years // Nauka i Zdravookhranenie [Science & Healthcare]. 2023, (Vol.25) 2, pp. 120-127. doi 10.34689/SH.2023.25.2.017Related publications:
ANALYSIS OF CLINICAL AND DEMOGRAPHIC INDICATORS OF PATIENTS WITH PARKINSON'S DISEASE IN THE SOUTHERN REGION OF KAZAKHSTAN
A COMPARATIVE STUDY OF DRUG POLICY REGARDING ORPHAN DISEASES IN THE USA, THE EUROPEAN UNION, AND THE REPUBLIC OF KAZAKHSTAN
MUTATIONS IN CARDIAC ION CHANNEL GENES IN KAZAKHSTANI PATIENTS WITH LONG QT SYNDROME
GENETIC FEATURES OF CONGENITAL DYSFUNCTION OF THE ADRENAL CORTEX CAUSED BY 21-HYDROXYLASE DEFICIENCY IN PERSONS OF KAZAKH NATIONALITY
NON-MOTOR SYMPTOMS IN PARKINSON'S DISEASE USING THE EXAMPLE OF AKTOBE PATIENTS